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Objectives: To review the serum vitamin D and supplementation levels for Pan-
creatic Insufﬁcient (PI) and Pancreatic Sufﬁcient (PS) children with CF and to
ascertain what percentage had a serum vitamin D >50 nmol/l and a serum vitamin D
>75 nmol/l.
Methods: Serum vitamin D (25-OHD) levels and dosage of vitamin D supplements
was collected on 28 children with PI CF and 5 with PS CF over a 1 year period.
All children and parents received information on dietary and life style sources of
vitamin D.
Results: 50% of the children with PI CF had a serum vitamin D >75 nmol/l (range
77.7–110.5 nmol/l) with 60% having >800 iu vitamin D3 per day (for these children
the median dosage was 1200 iu per day, range 900–2000 iu per day).
86% of children with PI CF had a serum vitamin D level >50 nmol/l.
40% of children with PS CF had a serum vitamin D level >75 nmol/l.
80% of children with PS CF had serum vitamin D level >50 nmol/l.
1 PI patient was deﬁcient but none were severely deﬁcient.
80% of PS patients received D3 supplementation (range 200–400 iu per day).
Conclusions: For both PS and PI children with CF the percentage of children
achieving a serum vitamin D >75 nmol/l was similar at around 50% with the
vast majority of patients (80% and 86% respectively) achieving levels >50 nmol/l
showing that aggressive vitamin D3 supplementation and dietary/lifestyle advice
on sources of vitamin D can be effective. The recommended dosage of 800 iu per
day of vitamin D in PI children would seem to be inadequate as the majority
of children (60%) needed a dosage higher than this to achieve 75 nmol/l. All the
children with PS CF required 400 iu Vitamin D3 daily to achieve a vitamin D
>75 nmol/l.
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Objectives: To determine the vitamin A status and appropriate supplementation
dosage of cystic ﬁbrosis (CF) patients who received vitamin A supplementation
based on annual serum retinol measurements.
Methods: Vitamin A food intake, supplementation dosage, and serum retinol levels
were obtained for 32 CF patients >4 years of age (4.3–27.3 years old) who had
pancreatic insufﬁciency and mild-to-moderate lung disease (percent predicted of
forced expiratory volume in 1 second >40%). These measurements were compared
with the dietary reference intake for healthy children and adults (D-A-CH dietary
recommendations), US and German CF recommendations, and serum retinol con-
centrations from National Health and Nutrition Examination Survey (NHANES)
data.
Results: Total vitamin A intake from food and supplementation was 315±182%
of D-A-CH-recommendations, with 65% from supplements. The range of the pre-
scribed vitamin A supplementation dosage was 0−20,000 IU/day (median 5500 IU),
and it was consistent with CF recommendations in 28% of participants. A quarter
of all patients did not need any vitamin A supplementation. The total vitamin
A intake exceeded the recommended upper limit of intake in 69% of subjects.
The mean (range) serum retinol was 38.6mg/dl (22.1–59.1mg/dl). All subjects had
serum retinol levels above 20mg/dl and below 72mg/dl (95th percentile of NHANES
reference range).
Conclusion: Individualized vitamin A supplementation of 0−20,000 IU/day based
on annual serum retinol measurements may prevent deﬁciency and high serum
retinol levels, but it may lead to vitamin A intake above the tolerable upper intake
level.
